Drug Recording and Classification by the WHO Research Centre for International Monitoring of Adverse Reactions to Drugs

Recording and classifying drugs reported in relation to suspected drug adverse reactions by fifteen countries has required the development of a special system. A comprehensive cross reference system between different types of drug names (INN, other nonproprietary names, trade names, etc.) and their occurrence in single and multiple ingredient products has been developed. Separate pharmacologic and therapeutic classifications designed for the needs of drug monitoring provide for farther special grouping.

On the basis of accumulated data, some analysis is given of reporting patterns and drug profiles in different countries.

Die Erfassung und Klassifikation von Arzneimitteln in Bezug auf schädliche Nebenwirkungen durch fünfzehn Länder hat die Entwicklung eines besonderen Systems erforderlich gemacht. Ein umfassendes Verweisungssystem für verschiedene Arten von Arzneimittelbezeichnungen (internationale chemische Kurzbezeichnungen, andere chemische Kurzbezeichnungen, Markennamen usw.) und ihr Vorkommen in Einund Mehrstoffprodukten wurde entwickelt. Separate pharmakologische und therapeutische Klassifikationen für die Erfordernisse der Arzneimittelüberwachung sehen eine weitere Spezialeinteilung vor.

Aufgrund der gesammelten Daten wird eine Analyse der Berichtsformen und Arzneimittelprofile in verschiedenen Ländern gegeben.

Key-words

Drug Recording System - Drug Classifications - WHO Drug Monitoring Centre - International Drug Profile

Schlüssel-Wörter

Arzneimittelerfassungssystem - Arzneimittelklassifikationen - WHO-Arzneimittelüberwachungszentrum - Internationale Arzneimittelprofile

• References

• 1 Ahlroth A, Aldama A, Christopher L, Helling M, Molander S, Venulet J. Methodology and some clinical research aspects of the WHO International Drug Monitoring Project. Drug Inform. Bull 05 1971; 45-48.
• 2 American Hospital Formulary Service. Bethesda, Maryland: American Society of Hospital Pharmacists y1968.;
• 3 Approved Names, British Pharmacopoeia Commission. London: Her Majesty’s Stationery Office; 1970
• 4 ÜLACOW N. W. (Edit.): Martindale: The Extra Pharmacopoeia. Ed. 26. London: The Pharmaceutical Press; 1972
• 5 Denominations communes des medicaments; Denominations fran§aises et denominations internationales recommandées. Paris: Doin; 1972
• 6 Drug Nomenclature Pbintout. Chicago: American Medical Association; 1968
• 7 EDA Chemical Dictionary. Washington, D.C: Food and Drug Administration; 1969
• 8 International Classification or Diseases, 1965 Revision. Geneva: World Health Organization; 1967
• 9 International Nonproprietary Names fob Pharmaceutical Substances, Cumulative List No. 3. Geneva: World Health Organization; 1971
• 10 Mauler E EJ. Pharmacological and Chemical Synonyms. A collection of names of drugs and other compounds drawn from the medical literature of the world. Ed. 5.. Amsterdam: Excerpta Medica Foundation; 1973
• 11 National Drug Code Diretory. Washington, D. C: Science Information Facility, Food and Drug Administration; 1969
• 12 Negwer M. Organisch-chemische Arzneimittel und ihre Synonyma (eine internationale Übersicht). Ed. 4.. Berlin: Akademie-Verlag; 1971
• 13 NFN-navne. NordiskaFarmakopénämnden. Ed. 3.. Stockholm: Almquist & Wiksell; 1965
• 14 Royall B. W, Venulet J. Methodology for international drug monitoring. Meth. Inform. Med 11 1972; 75-86.
• 15 Specifications for the Quality Contbol of Pharmaceutical Preparations, Second Edition of the International Pharmacopeia. Geneva: World Health Organization; 1967
• 16 Stecher P. (Edit.): The Merck Index. An encyclopedia of chemicals and drugs. Ed. 8.. Rahway, N. V: Merck & Co., Inc; 1968
• 17 USAN 10 and The TJSP Dictionary of Drug Names. Rockville, Maryland: U.S.P. Convention Inc; 1972
• 18 Anonymous: Off. Rec. Wld Hlth Org. 148 1966; 65-72.
• 19 Anonymous: Off. Rec. Wld Hlth Org. 160 1967; 29-30.
• 20 Anonymous: Off. Rec. Wld Hlth Org. 184 1970; 7-8.
• 21 Anonymous: Off. Rec. Wld Hlth Org. 184 1970; 54-66.